NFE2L2 and cancer: However, bardoxolone methyl also displays Nrf2-independent effects, including the direct inhibition of IκB kinase (IKK) and subsequent suppression of NF-κB signaling, which reduces pro-inflammatory cytokine production and can impair cancer cell survival.